Navigation Links
Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
Date:7/22/2013

SAN DIEGO, July 22, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), which is focused on the commercialization of compounded drug formulations utilizing the FDA 505(b)(2) development pathway, today announced it has received IRB approval for its Phase III clinical trial protocol of its lead product candidate, Impracor™. Imprimis has engaged Agility Clinical, Inc., a Carlsbad, CA-based consulting and contract research organization (CRO), to conduct the study at 20 - 30 US sites. The IRB-approved Phase III trial is a randomized, multicenter, double-blind, parallel-group study to assess the efficacy and safety of Impracor (ketoprofen 10% cream) compared with placebo in the treatment of acute pain (flare) associated with osteoarthritis (OA) of the knee.

As previously announced, Imprimis designed the Phase III study with the assistance of key opinion leaders, and also relied upon feedback from the U.S. Food and Drug Administration (FDA) following a Type C meeting between Imprimis and FDA officials in April 2013.

"This is an important and critical step forward for Imprimis as we prepare to start enrollment of our Phase III clinical trial in the third quarter of this year," said Imprimis CEO Mark L. Baum. "The IRB approval of this protocol in many ways represents the culmination of a year of hard work, and marks the initiation of our Impracor Phase III study. With Agility as our clinical operations team, we have an experienced partner that will help us bring forward a new alternative therapy in the space of anti-inflammatory, pain-relieving drugs, to improve patient h
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  LABSCO, the leading specialty ... products to hospitals, physician office laboratories and ... distributorship agreement with Sysmex America.  This agreement ... including the Sysmex XS-1000 i ™, Sysmex ... XN-Series Automated Hematology Analyzers. The ...
(Date:9/18/2014)... -- Casen Buswell has a rare vascular condition that causes his ... one of only 14 known cases of glomuvenous malformations plaque ... the United States , and one of only ... wave-length laser, is Methodist Children,s Hospital, a campus of Methodist ... laser available in South Texas only ...
(Date:9/18/2014)... , Sept. 18, 2014   Fruit Street Health ... an initial seed round of funding. ... led by a series of individual investors, the majority ... participated in the initial round are; Houston Cardiology ... Center Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
Breaking Medicine Technology:LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3
(Date:9/18/2014)... Older people become more physically vulnerable during bereavement, new ... hormones during bereavement changes with age, British researchers say. ... more likely to have weakened immune systems and develop ... and months after loss, we can suffer from reduced ... white blood cell and as such are essential at ...
(Date:9/18/2014)... GRAND PRAIRIE, Texas (PRWEB) September 18, 2014 ... available for the air medical transport industry, ShandsCair ... by Airbus Helicopters Inc . (AHI) at the ... Tenn. , The recently delivered and placed into service ... EC130 B4 that will be displayed at AMTC highlight ...
(Date:9/18/2014)... News) -- Daily supplements of selenium or vitamin E ... age-related cataracts among men, a new study indicates. ... could help prevent cataracts. To investigate this further, William ... School in Boston, and his colleagues examined data from ... The trial was initially designed to study prevention of ...
(Date:9/18/2014)... Lake City, UT (PRWEB) September 18, 2014 ... North America will be recognizing their shared fundraising impact ... on Thursday, Sept. 25. , The first-ever Dance Marathon ... more than $20 million projected to be raised by ... their community’s CMN Hospital. Donations generated through Dance Marathon ...
(Date:9/18/2014)... A group of international scientists have developed a new ... here . , The Wildlife Conservation Society (WCS)-led ... Tropical Diseases , describes the use of fecal samples ... have been exposed to the virus. This represents a ... can potentially change the way Ebola virus is studied ...
Breaking Medicine News(10 mins):Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 3Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 4Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3
... Opportunity International today,announced it has received a $4.5 million ... design, create and implement new electronic,and mobile banking technologies ... to more people in Sub-Saharan Africa. , ... by eBay founder,Pierre Omidyar and his wife Pam, has ...
... The Partnership to Fight Chronic DiseaseWASHINGTON, Feb. 24 A ... care - the first in a series of Health Care ... broad health care reform - will explore opportunities to deliver ... to promote health and incentivize better choices related to prevention ...
... Results Are InMUNDELEIN, Ill., Feb. 24 Sysmex ... and laboratory information systems developer today announced that ... industry for instrument reliability for its ninth consecutive ... In this annual report, Sysmex also ranked first ...
... women who have experienced high levels of family violence ... physical and mental health than their counterparts, found a ... Journal of Women,s Health . , "In general, there ... as depression and anxiety, and more chronic pain syndromes," ...
... review by The Lancet of the medical issues ... has reaffirmed its advice about the risks of venous thromboembolism ... increased "up to four-fold" by long-haul flight. , Dr Steen ... associated with an increase in deep venous thrombosis, which in ...
... scaling 94 flights in 9 minutes, 31 secondsCHICAGO, Feb. 23 ... up the Hancock stair climb event on Sunday, February 22. ... fight against lung disease, the third leading cause of death ... expected to raise more than $1 million to benefit Respiratory ...
Cached Medicine News:Health News:Omidyar Network Grants $4.5 Million to Opportunity International to Scale Technology-based Microfinance Services in Africa 2Health News:Omidyar Network Grants $4.5 Million to Opportunity International to Scale Technology-based Microfinance Services in Africa 3Health News:Omidyar Network Grants $4.5 Million to Opportunity International to Scale Technology-based Microfinance Services in Africa 4Health News:Making Progress on Health Reform: Where Does Fighting Chronic Disease Fit In? 2Health News:Sysmex Customer Satisfaction Ranks Highest in Independent Market Research 2Health News:Triple threat to health 2Health News:ESC reaffirms advice on cardiovascular risks associated with long-haul flights 2Health News:Over 4,000 Hustle Up the Hancock to Fight Lung Disease 2
For use with E5381 700 Circling Band (240 style)....
... mm. Storz offers the original Scleral ... A. Lincoff, M.D. The material is ... non-toxic and non-antigenic. Implants are soft ... intrusion. These implants are packaged sterile ...
For use under silicone strips E5381 610, E5381 611 and E5381 710. Indications: When higher buckle is required. Overall length: 6.1 mm....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Medicine Products: